MRX

Medicis (MRX)

Medicis Pharmaceutical Corp.

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:MRX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2012/12/10	20 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/12/10	20 : 02	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/12/06	22 : 15	Zacks	VRX and Gladerma Ink Revised Deal - Analyst Blog	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/12/06	08 : 51	PR Newswire (US)	Garmin Set to Join the S&P 500; R.R. Donnelly & Sons to Join S&P MidCap 400	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/12/06	06 : 31	PR Newswire (Canada)	Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/12/06	06 : 00	PR Newswire (US)	Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/12/06	05 : 37	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/12/06	05 : 37	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/29	06 : 22	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/29	06 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/29	06 : 21	Edgar (US Regulatory)	Annual Report (management Company) (nsar-b)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/29	06 : 20	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/29	06 : 20	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/28	22 : 00	Marketwired	Analyst Opinion on Mylan and Medicis Pharmaceutical - Acquisitions and Approvals Abound in Generic Drug Industry	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/28	22 : 00	PR Newswire (US)	Valeant Pharmaceuticals Announces New Management Appointments	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/28	09 : 00	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/21	20 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/21	20 : 05	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/21	20 : 05	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/21	20 : 05	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/20	22 : 45	Zacks	Valeant a Step Closer to Medicis - Analyst Blog	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/20	02 : 14	Zacks	Allergan to Buy SkinMedica - Analyst Blog	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/16	21 : 51	PR Newswire (US)	Valeant Pharmaceuticals Receives FTC Clearance For Medicis Acquisition	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/16	20 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/16	20 : 09	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/15	11 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/15	08 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/15	08 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/15	08 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:MRX	Medicis Pharmaceutical Corp.
2012/11/15	08 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:MRX	Medicis Pharmaceutical Corp.